Bunkerhill ECG-EF vs cmAngio®

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.

Bunkerhill ECG-EF

by Bunkerhill Health

cmAngio®

by CureMetrix

AI Verdict

These tools are adjacent in their focus on cardiovascular health but are not direct competitors. Bunkerhill ECG-EF analyzes ECGs to detect reduced left ventricular ejection fraction, aiding in early heart failure identification. In contrast, cmAngio® processes mammograms to detect breast arterial calcifications, providing insights into broader cardiovascular risk.

Choose Bunkerhill ECG-EF if…

Choose Bunkerhill ECG-EF if your primary goal is the early, non-invasive identification of patients at risk for heart failure by directly assessing left ventricular ejection fraction. This tool is ideal for integrating into routine cardiology workflows to quickly screen large populations using existing 12-lead ECG data.

View Bunkerhill ECG-EF →

Choose cmAngio® if…

Choose cmAngio® if you aim to leverage existing mammography screenings to gain additional insights into a woman's cardiovascular health risk. This solution is best suited for radiology practices looking to provide a non-invasive, opportunistic assessment of breast arterial calcifications without requiring additional patient procedures or radiation.

View cmAngio® →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature	Bunkerhill ECG-EF	cmAngio®
Pricing	Contact sales for pricing details.	Paid, out-of-pocket
Deployment	Cloud-native platform (Carebricks) that integrates with existing health system infrastructure like EHRs.	Cloud-based, integrates with any DICOM-compliant viewer
FDA Status	Yes AI-estimated	1 AI-estimated
HIPAA	Yes AI-estimated	Yes AI-estimated

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature	Bunkerhill ECG-EF	cmAngio®
Product Name	Bunkerhill ECG-EF	cmAngiou00ae
Company	BunkerHill Health	CureMetrix
Tagline	Generative AI for clinical reasoning and action.	Improving Healthcare for Women Globally through AI in Medical Imaging
Primary Function	Detects reduced Left Ventricular Ejection Fraction (LVEF u2264 40%) from 12-lead ECGs.	Detects Breast Arterial Calcifications (BAC) on mammograms.
Key Specialties	Cardiology, Emergency Medicine, Internal Medicine	Cardiology, Obstetrics & Gynecology, Radiology

Videos

Demos, reviews, and walkthroughs featuring Bunkerhill ECG-EF and cmAngio®.

Loading videos…

Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

What are the primary clinical applications and target patient populations for each tool?

Bunkerhill ECG-EF is designed for the early identification of patients at risk for heart failure by detecting reduced left ventricular ejection fraction (LVEF u2264 40%) from routine 12-lead ECGs. cmAngiou00ae focuses on detecting Breast Arterial Calcifications (BAC) on mammograms, primarily for women undergoing screening, to provide insights into cardiovascular health and aid early risk assessment.

What type of medical data does each AI tool analyze?

Bunkerhill ECG-EF analyzes routine 12-lead electrocardiogram (ECG) data. cmAngiou00ae processes both Full-Field Digital Mammography (FFDM) and Digital Breast Tomosynthesis (DBT) exams.

What specific clinical insights or findings do these AI tools provide?

Bunkerhill ECG-EF provides an AI algorithm to detect reduced Left Ventricular Ejection Fraction (LVEF u2264 40%), aiding in the early identification of patients at risk for heart failure. cmAngiou00ae offers AI-based detection and visualization of Breast Arterial Calcifications (BAC) location on a scorecard, enabling BAC identification and reporting for cardiovascular risk assessment.

How do these tools integrate into existing clinical workflows and IT infrastructure?

Bunkerhill ECG-EF integrates seamlessly with Electronic Health Records (EHRs) and clinical archives, including EMR or ECG Management Systems. cmAngiou00ae is compatible with any DICOM-compliant viewer and is designed for quick and easy installation.

Do these tools require additional patient procedures or expose patients to extra radiation?

Bunkerhill ECG-EF is a non-invasive, rapid, and accessible cardiac diagnostic tool that analyzes routine ECG data. cmAngiou00ae enables BAC identification and reporting without additional radiation or procedures, utilizing existing mammogram data.

More Comparisons

Assert-IQ vs Rapid Enterprise Platform

AISAP Cardio vs Rapid Enterprise Platform

AngioWaveNet vs Rapid Enterprise Platform

CorVista System with PH Add-On vs Rapid Enterprise Platform

More matchups featuring Bunkerhill ECG-EF or cmAngio®

Backers

Who funded each tool's parent company.

cmAngio®

Keshif Ventures